Trey Thoelcke |
The First Oral Cholesterol Pill Is Here. Which of These 5 Stocks Benefits Most?
The FDA just approved the first once-daily oral PCSK9 pill, and five major stocks now sit in the crosshairs. Not…
Alex Sirois |
Oracle is Falling Fast. Here’s Why This Wall Street Firm Believes The Stock Will Triple in 12 Months
Oracle just shed a third of its value in a month while sitting on a backlog that one top Wall…
Vandita Jadeja |
Over 60 Analysts Say Buy Microsoft. Here’s Our Price Target
Microsoft stock has lost nearly a fifth of its value this year while its AI business clocks a $37 billion…
Alex Sirois |
The Biggest Reason I’m Buying Alphabet Before the July 22 Earnings Report
The market is pricing Alphabet like a legacy ad company with an AI problem, and that gap between perception and…
Rich Duprey |
The Fastest-Growing Corner of Wall Street Could Make the Next Market Sell-Off Even Worse
Leveraged ETFs have quietly ballooned into one of Wall Street's fastest-growing corners, and the mechanics behind how they trade could…
Dr. Robert Castellano |
Micron Technology: Record DRAM Pricing Meets A Stock In Retreat
Micron just locked in five-year supply deals at historically high DRAM prices while a major AI cloud buyer quietly bets…
David Beren |
Why QDTE’s 0.97% Fee Costs You More Than Two Weeks of Payouts
QDTE prints a headline yield that turns heads, but the 0.97% fee is only the beginning of what this weekly…
Danielle Liverance |
Buffett’s Biggest Bet Just Dethroned Nvidia As the Largest Company In the World
Apple just clawed back the title of the world's most valuable company, and the man who bet billions on it…
Omor Ibne Ehsan |
The Megacap Growth ETF That’s Been Beating the S&P 500 for a Decade Straight
A virtually unknown megacap ETF has spent a decade quietly outperforming the S&P 500, yet most growth investors have never…
Rich Duprey |
Apple Just Toppled Nvidia as World’s Most Valuable Stock. Here’s Why the Gap Will Widen
Nvidia built the AI boom from the ground up, yet a company that spent a fraction of its rivals on…
Alex Sirois |
Coreweave Down 35% . This Analyst Reiterated His $250 Target Even After ‘Meta Compute’ Was Announced.
CoreWeave has lost nearly half its value in a year while one analyst just reaffirmed a price target that implies…
Vandita Jadeja |
Price Prediction: Two Big Reasons Oracle Stock Could Surge 60% This Year
Oracle's cloud backlog just shattered records while the stock collapsed to near its 52-week low, creating a gap between fundamentals…
David Moadel |
AMD Falls 5%, Intel Drops 4%, NVIDIA Slides 3% Before Recovering as Rotation Hits Semiconductor Stocks
A wave of selling swept through semiconductor stocks Friday as investors began questioning whether the AI spending boom can justify…
Joey Frenette |
Why AMD Stock Might Keep Outpacing Nvidia From Here
Nvidia holds the crown and a near-unbreakable moat, yet AMD shares have left Jensen Huang's juggernaut in the dust this…
Drew Wood |
Live In Manhattan Without Roommates. Here’s the Portfolio That Makes It Happen.
For many New Yorkers, roommates are not a college phase. They are the price of admission. Even professionals with solid…
Gerelyn Terzo |
Her Social Security Can’t Fund a Roth IRA. At 80, Her Hobby Income Can.
The oldest baby boomers, the class of 1946, are turning 80 this year and refusing to play the part. Dolly…
Joel South |
3 Healthcare REITs to Buy as America Ages in July
America's aging population is funneling hundreds of billions into healthcare each year, and three healthcare REITs are positioning to collect…
David Beren |
Warren Buffett Drops a Bombshell: He Was Responsible for Berkshire’s Push Into AI
At 95, Warren Buffett just revealed he personally drove one of Berkshire's most surprising recent bets, and his explanation raises…
John Seetoo |
The $5.25 billion ETF paying dividends that grew three years straight right now
DIVO has raised its monthly payout three years running and sits on $5.25 billion in assets, but one holding carries…
Rich Duprey |
This Bull Market Is Crushing History — Here’s Why Investors Shouldn’t Think It’s Over
Three and a half years of rate hikes, inflation scares, and recession warnings failed to stop this rally, and Goldman…
